|
|
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
Anne-Sophie Moreau
,
Yasmine Sebti
,
Alain Duhamel
,
Aldo M. Roccaro
,
Valérie Coiteux
et al.
Journal articles
istex
hal-00675965v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
Hermann Einsele
,
Javier Briones
,
Fabio Ciceri
,
Irene García-Cadenas
,
Fred Falkenburg
et al.
Journal articles
hal-03012806v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Total immunotherapy for Hodgkin lymphoma
Roch Houot
,
Reid W. Merryman
,
Franck Morschhauser
Journal articles
hal-02930371v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immune and Cell Therapy in Non-Hodgkin Lymphoma
Reid W. Merryman
,
Roch Houot
,
Philippe Armand
,
Caron Jacobson
Journal articles
hal-02890214v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cross-species analysis of enhancer logic using deep learning
Liesbeth Minnoye
,
Ibrahim Ihsan Taskiran
,
David Mauduit
,
Maurizio Fazio
,
Linde van Aerschot
et al.
Journal articles
hal-02961183v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Evidence for transcript networks composed of chimeric RNAs in human cells
Sarah Djebali
,
Julien Lagarde
,
Philipp Kapranov
,
Vincent Lacroix
,
Christelle Borel
et al.
Journal articles
hal-01216248v2
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Roch Houot
,
Tony Marchand
,
Nathalie Dhédin
,
Willy Lescaut
,
Anne Thiebaut-Bertrand
et al.
Journal articles
hal-01517054v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study
Bijal Shah
,
Armin Ghobadi
,
Olalekan Oluwole
,
Aaron Logan
,
Nicolas Boissel
et al.
Journal articles
hal-04069449v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
Bijal D Shah
,
Armin Ghobadi
,
Olalekan O Oluwole
,
Aaron C Logan
,
Nicolas Boissel
et al.
Journal articles
hal-03260932v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly
,
Jaffer A. Ajani
,
Jaroslaw Kuzdzal
,
Thomas Zander
,
Eric van Cutsem
et al.
Journal articles
hal-03217222v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid Merryman
,
Luca Castagna
,
Laura Giordano
,
Vincent Ho
,
Paolo Corradini
et al.
Journal articles
hal-03229516v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab
Aiping Chen
,
Fatima-Zohra Mokrane
,
Lawrence Schwartz
,
Franck Morschhauser
,
Apasia Stamatoullas
et al.
Journal articles
hal-02364994v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cretaceous African life captured in amber
A. Schmidt
,
V. Perrichot
,
M. Svojtka
,
K. Anderson
,
H. Belete
et al.
Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (16), pp.7329 - 7334. ⟨10.1073/pnas.1000948107⟩
Journal articles
insu-00600295v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chimeric antigen receptor (CAR) T-cells on the march from diffuse large B-cell lymphoma to mantle cell lymphoma
Roch Houot
,
Philippe Armand
,
Caron A Jacobson
Journal articles
hal-02569416v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas
Ajay K Gopal
,
Ronald Levy
,
Roch Houot
,
Sandip P Patel
,
Leslie Popplewell
et al.
Journal articles
hal-02563360v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
John Timmerman
,
Charles Herbaux
,
Vincent Ribrag
,
Andrew D. Zelenetz
,
Roch Houot
et al.
Journal articles
hal-02798009v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population
Samuel Vic
,
Jean Lemoine
,
Philippe Armand
,
François Lemonnier
,
Roch Houot
et al.
Journal articles
hal-04098893v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Roch Houot
,
Ronald Levy
,
Guillaume Cartron
,
Philippe Armand
Journal articles
hal-02929021v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|